Ann K Rosenthal Selected Research

Calcium Pyrophosphate

1/2022	Identification of Common Pathogenic Pathways Involved in Hemochromatosis Arthritis and Calcium Pyrophosphate Deposition Disease: a Review.
12/2021	Pathogenesis of calcium pyrophosphate deposition disease.
1/2021	Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition (CPPD) disease: A framework paper by the OMERACT CPPD working group.
1/2021	Management of calcium pyrophosphate crystal deposition disease: A systematic review.
1/2018	Review: Unmet Needs and the Path Forward in Joint Disease Associated With Calcium Pyrophosphate Crystal Deposition.
1/2018	Concurrence of rheumatoid arthritis and calcium pyrophosphate deposition disease: A case collection and review of the literature.
3/2015	Imaging of calcium pyrophosphate deposition disease.
5/2011	Crystal arthritis: calcium pyrophosphate deposition-nothing 'pseudo' about it!
9/2008	Promotion of articular cartilage matrix vesicle mineralization by type I collagen.
6/2008	Association between crystals and cartilage degeneration in the ankle.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ann K Rosenthal Research Topics

Disease

18	Osteoarthritis 01/2021 - 03/2002
12	Arthritis (Polyarthritis) 01/2022 - 05/2002
8	Chondrocalcinosis (Pseudogout) 12/2021 - 03/2002
6	Crystal Arthropathies 01/2021 - 05/2005
2	Rheumatoid Arthritis 01/2021 - 06/2015
2	Inflammation (Inflammations) 01/2018 - 03/2011
2	Joint Diseases (Joint Disease) 01/2018 - 05/2014
2	Ankylosis 05/2016 - 10/2013
1	Hemochromatosis (Bronze Diabetes) 01/2022
1	Pain (Aches) 01/2021
1	Rheumatic Diseases (Rheumatism) 01/2021
1	Synovitis 01/2018
1	Chronic Renal Insufficiency 01/2017
1	Osteoporosis 01/2017
1	Substance-Related Disorders (Drug Abuse) 01/2017
1	Gout 06/2015
1	Calcinosis 05/2015
1	Gouty Arthritis 05/2014
1	Hypertrophy 01/2014
1	Rupture 01/2007
1	Tendinopathy (Tendonitis) 01/2007

Drug/Important Bio-Agent (IBA)

13	Calcium PyrophosphateIBA 01/2022 - 03/2002
11	CalciumIBA 01/2017 - 03/2002
6	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 12/2021 - 05/2014
5	calcium phosphateIBA 10/2008 - 03/2002
4	Proteins (Proteins, Gene)FDA Link 05/2016 - 03/2004
2	TransglutaminasesIBA 09/2004 - 03/2004
1	Methotrexate (Mexate)FDA LinkGeneric 01/2021
1	magnesium carbonate (magnesite)FDA Link 01/2021
1	acetyl 4-aminosalicylic acidIBA 01/2021
1	Anti-Citrullinated Protein AntibodiesIBA 01/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021
1	Rheumatoid FactorIBA 01/2021
1	OsteoprotegerinIBA 01/2021
1	ORALIT (ORS)IBA 01/2017
1	diphosphoric acid (pyrophosphoric acid)IBA 05/2016
1	AcidsIBA 05/2016
1	MineralsIBA 06/2015
1	OsteopontinIBA 01/2014
1	OsteocalcinIBA 01/2014
1	Collagen Type XIBA 01/2014
1	Adenosine Triphosphate (ATP)IBA 10/2013
1	RNA (Ribonucleic Acid)IBA 02/2011
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2009
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2009
1	Proteoglycans (Proteoglycan)IBA 09/2008
1	Collagen Type I (Type I Collagen)IBA 09/2008
1	Uric Acid (Urate)IBA 06/2008
1	PoisonsIBA 03/2007
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 02/2006
1	Serine Proteases (Serine Protease)IBA 02/2006
1	EnzymesIBA 03/2004
1	epsilon-(gamma-glutamyl)-lysineIBA 03/2004

Therapy/Procedure

8	Therapeutics 01/2021 - 05/2006
1	Arthroplasty 01/2017
1	Knee Replacement Arthroplasty (Total Knee Replacement) 03/2002